Ambrx, Bristol-Myers in ADC cancer deal

Ambrx Inc. (La Jolla, Calif.) partnered with Bristol-Myers Squibb Co. (NYSE:BMY) to discover and develop

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE